Revascularisation and the diabetic patient: the potential role of drug-eluting stents

Br J Cardiol 2002;9:590-2 Leave a comment
Click any image to enlarge
Authors:

Revascularisation and the diabetic patient: the potential role of drug-eluting stents David Barrow David Barrow, a medical journalist with a special interest in interventional cardiology, discusses the potential benefit of drug-eluting stents in relationship to the revascularisation of the diabetic patient. It has been estimated that 13% to 25% of the patients undergoing coronary revas-cularisation procedures have diabetes and the diabetic patient continues to face higher mortality rates than non-diabetic patients after revascularisation. There is much debate on the preferred method of revascularisation in the diabetic patient: percutaneous transluminal intervention (PCI) or coronary artery bypass graft surgery (CABG).

Advertisement
Angina - BJC Learning programme
For healthcare professionals only

THERE ARE CURRENTLY NO COMMENTS FOR THIS ARTICLE - LEAVE A COMMENT